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ABSTRACT 
Objective: To study the pattern of drug interactions (DI) in our hospital and to identify whether it is associated with polypharmacy. To determine 
the level of severity of potential drug-drug interactions (PDDI), to detect, monitor and prevention of ADRs in the hospitalized patients and to 
identify the medication errors (ME).  
Methods: A prospective interventional study was conducted in a 300 bedded tertiary care South Indian hospital for a period of 6 mo. Prescriptions 
were analysed for PDDI using Micromedex software 2.2. The causality and severity of ADRs were assessed by using Naranjo’s, WHO UMC Scales and 
Hart wigs severity scales. ME was identified by review of patient drug charts.  
Results: Total 190 prescriptions were analyzed, in which 1028 drug interactions were seen. Out of which 718 were DDI, 198 DFI, 100 DEI, and 12 
DTI were observed. More number of DI was seen in cardiovascular drugs, antibiotics followed by antacids and antiulcer agents. A total of 52 ADRs 
were identified in 43 patients. Diuretics, cardiovascular drugs were associated with a higher incidence of ADRs followed by Anti-Diabetic agents. 58 
ME was seen in 190 prescriptions, among them omission error, prescribing errors and Wrong dose error was seen.  
Conclusion: Clinical pharmacist plays a potential role in the health care system in assisting the physician i.e. modifying the number of drugs taken, 
number of doses taken, medication adherence, identification of drug interactions, preventing, monitoring and detection of ADRs and identifying the 
medication errors. 
© 2019 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open-access article under the CC BY license (





The definition of polypharmacy in the literature is not uniform. 
However, the word ‘poly’ is a Greek word and means many or much. 
There are basically two approaches to the definition [1]. Analysis of 
prescription data could provide the bases for reviewing 
prescriptions practices and developing measures to promote the 
rational use of drugs and prevent drug-related problems. According 
to the WHO, the rational use of drugs requires that patients receive 
medications appropriate to their clinical needs, in doses that meet 
their own individual requirements, for an adequate period of time, 
and at the lowest cost to the and their community [2]. Furthermore, 
attention should be paid to the fact that the body of the older adults 
presents changes in their physiological functions that may lead to 
differentiated pharmacokinetics and greater sensitivity to both 
therapeutic and adverse drug effects. Pharmacokinetics, 
pharmacodynamics, and clinical outcomes are affected by a number 
of patient-specific factors, including age, sex, ethnicity, genetics, 
disease processes, polypharmacy, drug dose, and frequency, social 
factors, and many other factors [3]. Specifically, the burden of taking 
multiple medications has been associated with greater health care 
costs and an increased risk of adverse drug events (ADEs), drug 
interactions, medication non-adherence, reduced functional capacity 
and multiple geriatric syndromes [4]. The aim of the study was to 
evaluate the drug interactions (DIs), to assess, monitor and report the 
adverse drug reactions (ADRs) and to minimize medication errors. 
During hospitalisation, a frequency of major and moderate drug-
drug interactions per patient was 1.11, which was higher compared 
to hospital admission or to hospital discharge. Incidence of potential 
drug-drug interactions was very high almost in 89% of all 
prescriptions. The prevalence of ADR’s at admission was 12.4% and 
ADR’s causing admission was 8.1%. Overall incidence of serious 
ADR’s was 6.7% and of fatal ADR’s was 0.32% of hospitalized 
patients. Prescribing errors are the most frequent subtype of 
medication errors, occurring in 7% medication orders, 50% of 
hospital admissions and 2% of inpatients. ADR’s remain a significant 
contributing factor to morbidity and mortality. There is a definite 
need to further understand the incidence and prevalence of ADR’s in 
an ambulatory population. 
By this type of study, we can give individualised treatment to each 
patient that increase the quality of life and further expect outcomes 
prior to and increasing the safety of drug use. 
MATERIALS AND METHODS 
Place of the study: All departments in a 300 bedded tertiary care 
South Indian Hospital. 
Study design: This study is a prospective interventional study using 
inpatient prescriptions from different departments in a 300 bedded 
tertiary care South Indian hospital.  
Study population: 190 prescriptions were screened  
Study duration: 6 mo from September to February 
Ethical approval was taken from our hospital Vishwa Bharathi 
multispecialty hospital, Kurnool, Andhra Pradesh. 
Eligibility criteria 
Patients are enrolled in the study based on inclusion and exclusion 
criteria 
Inclusion criteria 
Prescription with more than 3 drugs, those who stayed greater than 
24 h in the hospitals was included. Both Age groups greater than 15 
y and the patients who are willing were included in this study.  
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Patients who are uncooperative, not willing to participate in the 
study were excluded from the study. Pregnancy and lactating 
women, incomplete patient medical records were excluded. Patients 
who are consuming other than allopathy medications and those who 
stayed<24 h in the hospitals were excluded. Patients who are 
diagnosed to have HIV and tuberculosis (TB) and patients who are 
taking chemotherapy and radiation therapy were excluded from the 
study. 
Study protocol 
A total of 190 prescriptions were selected. Cases and controls were 
identified by using a computerized DI database system (Micromedex 
2.2 version). 
Methods for detecting drug interactions 
As research better explains the biochemistry of drug use, fewer 
ADRs (adverse drug reactions) are Type B and more are Type A.  
Methods for detecting adverse drug reactions 
Causality assessment 
A separate data entry format was specially designed including the 
drug chart, ADRs algorithm, and causality assessment scale. The 
identification of drug interactions, ADRs and medication errors was 
done through routine ward round participation and prescription 
monitoring of hospitalized patients and op patients in all 
departments. The reports were obtained from health care 
professionals (nurses, doctors etc). Data were collected from 
patient’s case sheet and transferred to data entry format for 
evaluation. 
Methods of detecting an ADR 
Spontaneous monitoring 
In spontaneous monitoring, treating physician’s record suspected 
ADRs using reporting cards.  
Intensive monitoring 
Intensive monitoring is based upon the systematic evaluation of link 
between the adverse event and drugs involved, patients admitted 
were followed up until discharged. 
Performed screening of patients arriving to a hospital and among 
them 100 patients taking cardiovascular drugs was included in the 
study after obtaining inform consent form. The ADRs developed was 
discussed with the physician and De-challenge or Re-challenge was 
done based on the ADR severity. The causality and severity 
assessment were done using Naranjo, WHO-UMC scales, Hart wigs 
scale and Rawlins and Thompson ADRS respectively. 
Methods for detecting medication errors 
The major methods for detecting adverse events are chart review, 
computerized monitoring, incident reporting, and searching claims 
data. Medication errors are mainly detected by means of direct 
observation, voluntary reporting (by doctors, pharmacists, nurses, 
patients, and others) and chart review and incident reporting. 
RESULTS 
The study was conducted in the in-patient department of tertiary 
south Indian hospital for a period of 6 mo. Total drugs used in the 
190 prescriptions were 1867 drugs. The average number of drugs 
per prescription was 9.82. 
 
Categorisation of polypharmacy 
Table 1: Categorisation of polypharmacy 
S. No. No of drugs No of prescriptions Percentage 
1 Less than 6 7 3.684 
2 Equal to 6 9 4.736 
3 More than 6 174 91.578 
 Total 190 100 
 
The total number of prescriptions which contains more than 6 drugs 
were predominantly high 174(91.57%) cases whereas 9(4.736%) 
prescriptions contains equal to 6 drugs and 7(3.68%) prescriptions 
contains less than 5 drugs were shown in table 1.  
A total of 185 prescriptions were found to have drug interactions in 
190 prescriptions. Out of which 127(69.24%) were males in which 
713 drug interactions were seen, out of 713 drug interactions 
482(67.60%) drug-drug interactions were seen, 119(16.69%)drug-
food interactions were seen, 100(14.02%) drug-ethanol interactions 
were seen and 12(1.68%) drug-tobacco interactions were seen. 315 
drug interactions were seen in 63(33.15%) females, out of which 
236(74.92%) drug-drug interactions were seen, 79(25.07%) drug-
food interactions were seen. Age was found to be an important 
criterion in the fact that the patient in the age group 51-70 y had 
experienced maximum drug interactions (in cardiology 
department). 
Classification of drug interactions  
Among that 1028 drug-drug interactions were seen, in which 
419(58.35%) were major, 255(35.51%) were moderate and 
44(6.12%) were minor.198 drug-food interactions were seen, in 
which 2(1.01%) were major, 88(44.44%) were moderate and 
108(54.54%) were minor.100 drug ethanol interactions were seen, 
in which 59(59%) were major, 40(40%) were moderate.12 drug-
tobacco interactions were seen, in which 8(66.66%) were major, 
4(33.33%) were moderate were shown in table 2. 
 
Table 2: Severity of drug interactions 
S. No. Severity DDI DFI DEI DTI 
1 Major 419(58.35) 2(1.01) 59(59) 8(66.66) 
2 Moderate 255(35.51) 88(44.44) 40(40) 4(33.33) 
3 Minor 44(6.12) 108(54.54) 1(1) 0(0) 
 Total 718(100) 198(100) 100(100) 12(100) 
 
Class wise distribution of drugs 
Antibiotics, Cardiovascular drugs followed with NSAIDS are the 
major class of drugs with interactions in our study. 
In this study antibiotics (13.13%) and cardiovascular drugs 
(13.13%) are associated with high number of drug interactions 
followed by antacids(11.11%), NSAIDS (7.07%), Corticosteroids 
(7.07%), antipsychotics (7.07%), antidiabetics (6.06%), 
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anticonvulsants (5.05%), antiplatelet (5.05%), anticoagulants 
(5.05%), diuretics (4.04%), anti TB agent s (4.04%), antiasthma 
agents (3.03%), antiemetic’s(2.02%), vitamins and minerals 
(2.02%), anti-malarial(1.01%), antifungal agents (1.01%), anti-
amoebic (1.01%), anti-thyroids agents(1.01%) and inotropic 
agents(1.01%) were shown in fig. 1. 
 
 
Fig. 1: Class-wise distribution of drugs 
 
Gender wise distribution of ADRs 
Out of 52 ADRs, 36(69.23%) ADRs were identified in males and 
16(30.76%) ADRs were identified in females. Thus high 
incidence of ADRs was reported in males. The most vulnerable 
age group that is prone to ADRs in this study was 61-70 y group 
of patients. 
Severity assessment of ADRs 
The severity assessment of ADRs as mild, moderate, severe was done by 
using Hart wigs scale. Causality assessment is the method by which the 
extent of the relationship between the drug and suspected reaction is 
established. Among different causality scales, the Naranjo’s scale and 
WHO-UMC scale of assessment are most commonly used. 
 
Table 3: Severity assessment of ADRs 
Causality No of ADRs % OF ADRS 
Mild 6 11.53 
Moderate 38 73.07 
Severe 8 15.38 
Total 52 100 
The severity assessment by modified Hart wig’s scale showed that 6 (11.53%) ADRs were mild, 38(73.07%) ADRs were moderate and 8(15.38%) 
ADRs were severe were shown in table 3. 
 
Table 4: Causality assessment of ADRs by Naranjos scale 
Causality No of ADRs % OF ADRS 
Definite 10 19.23 
Probable 10 19.23 
Possible 32 61.53 
Total 52 100 
 
Causality assessment of ADRs by naranjo’s scale 
The assessment by Naranjo’s scale showed that out of 52ADRs, 
10(19.23%) ADRs are definite, 10(19.23%) ADRs are probable and 
32(61.53%) ADRs are possible were shown in table 4. 
 
Causality assessment of ADRs by WHO-UMC scale 
 
Fig. 2: Causality assessment of ADRs by WHO-UMC scale 
The assessment by WHO-UMC scale showed that out of 52ADRs, 
6(11.53%) ADRs were certain, 6(11.53%) ADRs were possible and 
40(76.92%) ADRs were probable were shown in fig. 2.  
Distribution of ADRs based on drug class 
In this study diuretics (28.84%) and cardiovascular drugs (23.07%) 
are associated with a high number of ADRs, followed by antidiabetic 
agents (13.46%).  
In this study, diuretics were found to cause ADRs of electrolytic 
imbalances like hyponatremia-8, hypokalemia-4, hyperkalemia-2, and 
hypomagnesemia-1. Followed by cardiovascular drugs were found to 
cause constipation-1, headache-3, palpitation-1, dizziness-1, Nausea-1, 
vomiting-1, cough-2, bloating-2. Antidiabetic agents cause 
hypoglycaemia-5, CKD-1, hyperkalemia-1. Antibiotics were found to 
cause ADRs like mild diarrhoea-1, SJ syndrome-1, hypokalemia-1, 
nausea, and vomiting-1. Anticoagulants cause hypotension-2, sinus 
bradycardia-1. Anti TB agents cause altered liver enzymes-1, decreased 
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appetite-1, dark colour urine-1. Antacids and antiulcer agents cause 
constipation-2. Anticonvulsants cause sore throat-1, slurred speech-1. 
Anticholinergic agents cause psychosis-1. Corticosteroids cause 
ecchymosis-1 and NSAIDS cause SJ syndrome-1. 
  
 
Fig. 3: Class wise distribution of ADRs 
 
Out of 58 medication errors, 37(63.79%) were identified in males and 21 
(36.20%) were identified in females. The most vulnerable age group that 
is prone to ME were 41-50 y age group of patients. A total of 190 cases 
were categorised according to types of ME. The commonly seen MEs are 
prescribing error, dispensing error, wrong drug error, wrong dose error, 
omission error, wrong time error, and compliance error. 
Pharmacist intervention 
By performing the intervention, the pharmacist evaluation 
shows that out of 190 cases, 104 (54.73%) are solved, 
52(27.36%) are partially solved and 34(17.89%) cases are not 
solved. The outcome of pharmacist evaluation was shown in 
table 6. 
 
Categorisation of medication error 
Table 5: Categorisation of medication error 
Type of error  A B C D E F G H I Total  Percent  
Prescribing Error 0 2 8 0 0 3 0 0 0 13 22.413 
Dispensing Error 0 0 2 0 0 0 0 0 0 2 3.448 
Wrong Drug Error 0 0 6 0 0 0 0 0 0 6 10.344 
Wrong Route Error 0 0 0 0 0 0 0 0 0 0 0 
Wrong Dosage Form Error 0 0 0 0 0 0 0 0 0 0 0 
Wrong Dose Error 0 5 7 0 0 0 0 0 0 12 20.689 
Omission Error 0 5 13 0 0 0 0 0 0 18 31.034 
Wrong Drug preparation Error 0 0 0 0 0 0 0 0 0 0 0 
Wrong Drug Administration Technique Error 0 0 0 0 0 0 0 0 0 0 0 
Wrong Time Error 0 1 0 0 0 0 0 0 0 1 1.724 
Wrong Patients 0 0 0 0 0 0 0 0 0 0 0 
Compliance Error 0 2 4 0 0 0 0 0 0 6 10.344 
Total  0 15 40 0 0 3 0 0 0 58 100 
 
Table 6: Pharmacist intervention 
Pharmacist evaluation Frequency Percentage 
Solved 104 54.73 
Partially solved 52 27.36 
Not solved 34 17.89 
TOTAL 190 100 
 
DISCUSSION 
Polypharmacy was the frequent condition in Indian scenario and 
mainly depends upon the type of the diseases, comorbid conditions, 
hereditary, economic status and malnutrition. 
Many medications have potential interactions with other drug or 
substance when prescribed together, according to the WHO 
definitions, the average number of drugs per person was within the 
range of 1.4-2.4. The present study found that an average number of 
drugs prescribed for patients was 9.82, showed the presence of 
polypharmacy. 
Total of 1028 drug interactions was seen in 190 patients. The 
present study showed a prevalence of drug interactions were more 
in males 482(67.13) when compared to females 236(32.86). 
Some other studies found a similar association which supports to 
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our findings which were conducted by John et al. and mistry et al. 
[5].  
In the present study maximum numbers of drug interactions were 
seen in 51-70 y age group. This result was in accordance with results 
of the study by the John et al. [5].  
In this study, more number of drug interactions were observed in 
cardiology department 538 (52.33 %) in the previous study by g. 
Murtaza et al. showed the incidence of drug interactions were high in 
cardiology department[6]. In contrast to the study by John et al. 
showed less number of drug interactions in cardiology department [5].  
The present study showed prescriptions which contain more than 6 
drugs were predominately high 174 (91.57 %) which was similar to 
the study conducted by Ashok et al. [7].  
The study conducted by kumara Swamy Rc et al. showed the average 
number of drugs per individual patient was 5.95 the present study 
showed that the average number of drugs per individual patient was 
9.82[8]. Thus the increasing number of drugs increases the risk of 
occurrence of drug-drug interactions, ADRs exponentially 
(Gunasekaran et al.) [9]. 
Most of the drug interactions in our study were of major drug 
interactions 488 (47.47%) while the other study performed by John 
et al. showed most of the drug interactions were moderate [5]. 
The present studies showed that high numbers of drug interactions 
were seen due to cardiovascular drugs 13(13.13%). the study which 
supports our findings was a study conducted by G. Murtaza et al. [6]. 
Most of the interactions in the present study were pharma-
codynamics interactions 409(56.96%) were followed by 
pharmacokinetic interactions 309(43.04%) which was supported by 
the study performed by Kapadia et al. [10]. 
A total of 190 patients have included in the study out of them 43 
patients developed 52 ADRs, out of which 36(69.23%) ADRs were 
identified in male and 16(30.76%) ADRs were identified in females. 
In the previous study by M Sureswara reddy et al., showed the high 
percentage of ADRs in male [11]. A study by Desai et al., revealed a 
high percentage of ADRs in male [12]. Another study conducted by 
Jayanthi et al., showed male predominance [13]. 
The present study showed that 61-70 y age group patients were 
more prone to ADRs 15(28.845). these results are in accordance 
with the results of the study by Jayanthi et al.,which revealed a 
higher incidence of ADRs in patients age greater than 60 [13]. 
In the present study severity assessment is done by modified hart 
wig’s scale showed 38(73.07%) moderate ADRs, 8(15.38%) severe 
ADRs and 6(11.53%) mild ADRs were seen. A previous study by 
Madhavan trivedi et al., showed a high number of 34 moderate ADRs 
[14]. In contrast to the present study by Jayanthi et al. showed a high 
number of mild ADRs [13]. 
In this study, Causality assessment was done by using both Naranjo’s 
scale and WHO-UMC scale. According to Naranjo’s scales out of 52 
ADRs10 (19.23%) were definite, 10(19.23%) ADRs were probable 
and 32(61.53%) ADRS were possible. A study by Muthiah 
Palaniappan et al. showed that the majority of ADRs were possible 
and remaining ADRs were possible [15]. 
According to WHO-UMC scale out of 52 ADRs 6(11.53%) ADRs were 
certain, 6(11.53%) ADRs were possible and 40(76.925) ADRs were 
probable. A study by Jayanthi et al. showed the most of the ADRs 
were probable [13].  
In the present study, the highest number of ADRs were due to 
diuretics 15(28.84%) followed by cardiovascular drugs 12(23.07%). 
In contrast to the present study by M Sureswara Reddy et al., 
showed the highest number of ADRs in cardiovascular drugs 
followed by diuretics [11]. 
One fatal ADR was observed during the study period. Symptomatic 
treatment was given for 22(42.30%) ADRs, a drug withdrawn are 
alternative treatment was given for 21 (42.30%) ADRs and no 
change in the treatment was made for 9 (17.30%) ADRs in the study. 
These results are in accordance with the interventions of the study 
by Sagar B Bhagat et al. [16]. 
In the present study more number of omission errors 18(31.03%) 
and most commonly seen the category of medication errors were 
type C followed by type B. the study performed by the Syed Umer Jan 
et al., showed the high percentage of omission errors which was 
similar to our study [17]. Another study conducted by Hou Ning et 
al., showed more number of type B errors followed by type C errors 
which were the contrast to our study [18].  
Limitations of the study 
The current study evaluated the occurrence of DIs, ADRs and 
medication error at a single hospital that may not occur in another 
hospital, so a pilot study needs to be conducted throughout the 
country. Since DIs and ADRs can differ between patients based on 
disease condition and genetic characteristics. There is a possibility that 
many ADRs could have been unrecognized or unreported in the study. 
This study has a limitation of being a short term study which yields 
52 ADRs The complete causality assessment could not be done due 
to not practicing re-challenge (not possible or not performed) for 
most of the cases. We probably failed to detect some errors, 
particularly administration errors. More reliably by trained 
observers following nurses during routine patient care activities 
CONCLUSION 
Finally, the study concluded that through multiple medications are 
seen in prescriptions can be accepted as they are appropriate to the 
present clinical condition but monitoring was required for the 
occurrence of drug-related problems. Hence Clinical pharmacist 
plays a potential role in the health care system in assisting the 
physician i.e. modifying the number of drugs taken, number of doses 
taken, medication adherence, identification of drug interactions, 
preventing, monitoring and detection of ADRs and identifying the 
medication errors. This will improve the patient quality of life and 
decreasing the health care costs of patients. So the Clinical 
pharmacist intervention plays a major role in both humanistic and 
clinical outcomes along with economic outcomes. 
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